Syntacoll GmbH
Biotechnology, Chemical Industry, Medical Technology
-
Short facts
-
- Manufacturer
- Year founded 1992
- 64 Employees (site)
- Turnover: <5m EUR
Products/services: Our lead pipeline products at advanced stages in clinical development include XaraColl in phase 3 for the treatment of post-operative pain, and Cogenzia in phase 3 for the treatment of diabetic foot infections. CollaGUARD, an adhesion barrier, is ready to enter a pivotal study required for approval in the United States. Collagen products ; Disposable articles, veterinary ; Sports medical physio-therapeutical preparations
Basic data
Company
Syntacoll GmbH
Street
DonauStr. 24
PC / City
93342 Saal a.d.Donau
County
Lower Bavaria
Phone
+49 9441 6860-0
Fax
+49 9441 6860-30
Homepage
Language skills
English, German
Profile/competences
Core competencies
not available
Key sectors / sub-sectors
- Biotechnology: Prophylactic drug development
- Biotechnology: Technical services for biotechnology
- Biotechnology: Therapeutic drug development
- Chemical Industry: Pharmaceutical preparations
- Medical Technology: Veterinary medicine equipment and instruments
NACE industries
- Other printing 18.12
- Manufacture of other articles of paper and paperboard 17.29
- Manufacture of plastics products 22.2
- Manufacture of basic pharmaceutical products and pharmaceutical preparations 21
Certifications
not available
Sales markets - target industries
not available
Sales markets - target countries
not available
Cooperation offers
not available